KC startup pairs with blockchain platform to build trust, value in premium beef genetics

January 31, 2024  |  Startland News Staff

A newly announced strategic collaboration is expected to help Lenexa-based Vytelle promote the value of feeder cattle, while simultaneously bringing more transparency to a critical market segment within the beef industry.

Kerryann Kocher, Vytelle

The initiative between Vytelle and BlockTrust Network — an API-driven platform that leverages blockchain technology to enhance trust within the beef supply chain — marks the first of its kind aimed to leverage their respective strengths targeting the feeder cattle market.

“We are thrilled to embark on this groundbreaking collaboration with Blocktrust,” said Kerryann Kocher, CEO of Vytelle, the fastest growing, independent IVF company and curator of the world’s largest feed efficiency database.

Collaboration is a step forward in building markets that acknowledge the value of premium genetics for Vytelle’s seedstock customers by increasing the demand for their progeny, she added.

Gregg Barfield, Blocktrust Network

Leveraging the power of the Vytelle’s industry leadership in characterizing feed efficient genetics, Vytelle will develop tools to characterize differences in feed efficiency among groups of feeder cattle via the Blocktrust Network’s permissioned blockchain, the company said. This information will provide buyers unique insights on the value of cattle, shining a spotlight on the premium value of calves sired by bulls from breeding programs that are driving genetic improvement in feed efficiency, a critical driver of profitability and sustainability in cattle feeding.  

“Blockchain technology has proven to be a transformative force across various industries and Blocktrust Network is thrilled to bring a new level of transparency to the beef supply chain,” said Gregg Barfield, CEO of Blocktrust Network, which is headquartered in College Station, Texas. “The opportunity to classify cattle individually based on their genetics and performance through harvest will unlock markets and value for smaller producers to participate in quality-driven sustainable supply chains.”

Tagged , , ,
Featured Business
    Featured Founder
      [adinserter block="4"]

      2024 Startups to Watch

        stats here

        Related Posts on Startland News

        Google lauds Kansas City tech in congressional hearing

        By Tommy Felts | July 23, 2015

        Dirt off your shoulder, Kansas City. Search engine giant Google added a proverbial feather to Kansas City’s tech hat Thursday while testifying in a U.S. Congressional hearing. In a hearing with the House Energy and Commerce Subcommittee on Communications and Technology, the tech titan said Kansas City has been transformed as a result of Google Fiber’s…

        Events Preview: Athena League, investor pitch

        By Tommy Felts | July 23, 2015

        There are a boatload of entrepreneurial events hosted in Kansas City on a weekly basis. Whether you’re an entrepreneur, investor, supporter, or curious Kansas Citian, we’d recommend these upcoming events for you. WEEKLY EVENT PREVIEW Don’t miss out tonight Athena League July VOX When: July 23 @ 5:30 pm – 7:30 pm Where: Village Square Coworking Studio…

        Sharing economy hits agriculture with FarmLink service

        By Tommy Felts | July 23, 2015

        A new-age economic model is entering the world’s oldest industry. Kansas City-based FarmLink introduced this week its Web-based farm equipment sharing community MachineryLink Sharing, which the company says will enable farmers to save money and generate revenue. “Agriculture is in the midst of its next big transformation, where new thinking and business models that have revolutionized…

        Metactive lands $224K for nonclinical studies

        By Tommy Felts | July 22, 2015

        Olathe-based Metactive Medical recently secured a grant that will continue the development of its embolization device that fights cancer. The National Institutes of Health awarded Metactive $224,000 that will fund nonclinical studies on the performance of the company’s Blockstent Microcatheter embolic devices for the occlusion — or blockage — of peripheral arteries and veins. “We believe…